Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma

Xianming Huang; Jian Gong; Dan Ye; Van Nguyen; Shen Yin; Rich Archer; Chris Hughes; Rolf Brekken; Jeff Hutchins; Alan Schroit; Bruce Freimark

doi:10.1186/2051-1426-2-S3-P205

Article info

Poster Presentation

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma

Free

Authors

Xianming Huang Department of PharmacologyUT Southwestern Medical Center Dallas TX USA PubMed articles Google scholar articles
Jian Gong Peregrine Pharmaceuticals, Inc Tustin CA USA PubMed articles Google scholar articles
Dan Ye Department of SurgeryUniversity of Texas, Southwestern Medical Center at Dallas TX USA PubMed articles Google scholar articles
Van Nguyen Peregrine Pharmaceuticals, Inc USA PubMed articles Google scholar articles
Shen Yin Peregrine Pharmaceuticals, Inc USA PubMed articles Google scholar articles
Rich Archer Peregrine Pharmaceuticals, Inc Tustin CA USA PubMed articles Google scholar articles
Chris Hughes University of California Irvine CA USA PubMed articles Google scholar articles
Rolf Brekken Department of PharmacologyUT Southwestern Medical Center Dallas TX USA PubMed articles Google scholar articles
Jeff Hutchins Department of Clinical AffairsPeregrine Pharmaceuticals Inc. Tustin CA USA PubMed articles Google scholar articles
Alan Schroit Department of SurgeryUniversity of Texas, Southwestern Medical Center at Dallas TX USA PubMed articles Google scholar articles
Bruce Freimark Peregrine Pharmaceuticals, Inc Tustin CA USA PubMed articles Google scholar articles

Citation

Huang X, Gong J, Ye D, et al

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma

Journal for ImmunoTherapy of Cancer 2014;2:P205. doi: 10.1186/2051-1426-2-S3-P205

Publication history

First published November 6, 2014.

Online issue publication

March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password